Pemoline in ADHD.
作者信息
Winsberg B, Barbato M
出版信息
J Am Acad Child Adolesc Psychiatry. 1997 Dec;36(12):1649-50. doi: 10.1097/00004583-199712000-00007.
Abstract
摘要
相似文献
1
Pemoline in ADHD.
J Am Acad Child Adolesc Psychiatry. 1997 Dec;36(12):1649-50. doi: 10.1097/00004583-199712000-00007.
2
Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder.
J Am Acad Child Adolesc Psychiatry. 2011 May;50(5):480-9. doi: 10.1016/j.jaac.2011.02.007. Epub 2011 Apr 7.
3
Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1149-50; author reply 1151-2. doi: 10.1016/j.pnpbp.2007.03.018. Epub 2007 Apr 1.
4
OROS methylphenidate in the treatment of adults with ADHD: a 6-month, open-label, follow-up study.
Ann Clin Psychiatry. 2010 Aug;22(3):196-204.
5
Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
J Child Adolesc Psychopharmacol. 2004 Summer;14(2):243-54. doi: 10.1089/1044546041649020.
6
Coming into focus. Pharmacologic treatment for ADHD.
Adv NPs PAs. 2010 Dec;1(4):16-22; quiz 23.
7
Pemoline (Cylert): market withdrawal.
CMAJ. 2000 Jan 11;162(1):106, 110.
8
A symposium on Attention Deficit Hyperactivity Disorder (ADHD). Developments in treatment.
Aust N Z J Psychiatry. 2002 Aug;36(4):477-9. doi: 10.1046/j.1440-1614.2002.t01-1-01065.x.
9
Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures.
J Am Acad Child Adolesc Psychiatry. 1995 Nov;34(11):1504-13. doi: 10.1097/00004583-199511000-00018.
10
An open trial of pemoline in drug-dependent delinquents with attention-deficit hyperactivity disorder.
J Am Acad Child Adolesc Psychiatry. 1996 Aug;35(8):1018-24. doi: 10.1097/00004583-199608000-00012.
Zotero 插件